| Title |
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease
|
|---|---|
| Published in |
Open Access Journal of Clinical Trials, January 2020
|
| DOI | 10.2147/oajct.s221914 |
| Pubmed ID | |
| Authors |
Boris Decourt, Jeffrey Wilson, Aaron Ritter, Christopher Dardis, Frank P DiFilippo, Xiaowei Zhuang, Dietmar Cordes, Garam Lee, Nadia D Fulkerson, Tessa St Rose, Katurah Hartley, Marwan N Sabbagh |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 40% |
| Unknown | 3 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 69 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 9 | 13% |
| Student > Bachelor | 7 | 10% |
| Researcher | 7 | 10% |
| Lecturer | 3 | 4% |
| Other | 3 | 4% |
| Other | 7 | 10% |
| Unknown | 33 | 48% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 13% |
| Neuroscience | 5 | 7% |
| Biochemistry, Genetics and Molecular Biology | 4 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Nursing and Health Professions | 3 | 4% |
| Other | 9 | 13% |
| Unknown | 36 | 52% |